Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor
<p>Abstract</p> <p>Background</p> <p>Borderline ovarian tumors (BOTs) are a subset of epithelial ovarian tumors with low malignant potential but significant risk of relapse (10% to 30%). Unfortunately, surgical prognostic factors for BOT relapse have not been clearly id...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2013-01-01
|
| Series: | World Journal of Surgical Oncology |
| Subjects: | |
| Online Access: | http://www.wjso.com/content/11/1/13 |
| _version_ | 1818061091357327360 |
|---|---|
| author | Romeo Margarita Pons Francesc Barretina Pilar Radua Joaquim |
| author_facet | Romeo Margarita Pons Francesc Barretina Pilar Radua Joaquim |
| author_sort | Romeo Margarita |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Borderline ovarian tumors (BOTs) are a subset of epithelial ovarian tumors with low malignant potential but significant risk of relapse (10% to 30%). Unfortunately, surgical prognostic factors for BOT relapse have not been clearly identified, probably due to the use of heterogeneous surgical definitions and limited follow-up. The aim of this study was to assess potential relapse risk factors using standard surgical definitions and long follow-up.</p> <p>Methods</p> <p>All patients diagnosed with BOT for a period of more than 10 years in a single institution were included in the analysis. Complete surgical staging was defined as the set of procedures that follow standard guidelines for staging surgery (except lymphadenectomy), performed either with one or two interventions. Fertility-sparing surgeries that preserved one ovary and the uterus but included all the remaining procedures were classified as complete staging. The relationship between potential risk factors and time to BOT relapse was assessed by log-rank tests corrected for multiple comparisons and Cox regression.</p> <p>Results</p> <p>Forty-six patients with a median follow-up of 5.4 years were included, of whom 91.3% had been diagnosed as FIGO stage I disease and 45.7% had received complete staging surgery. Five relapses were detected (10.9%), all of them in women who had been diagnosed with stage I disease and had received incomplete staging surgery. Log-rank tests confirmed the association between incomplete staging surgery and shorter time to BOT relapse.</p> <p>Conclusions</p> <p>Complete staging surgery should be considered a cornerstone of BOT treatment in order to minimize the risk of relapse.</p> |
| first_indexed | 2024-12-10T13:42:48Z |
| format | Article |
| id | doaj.art-b8cb6817107c4a1e8de04c3c5491defb |
| institution | Directory Open Access Journal |
| issn | 1477-7819 |
| language | English |
| last_indexed | 2024-12-10T13:42:48Z |
| publishDate | 2013-01-01 |
| publisher | BMC |
| record_format | Article |
| series | World Journal of Surgical Oncology |
| spelling | doaj.art-b8cb6817107c4a1e8de04c3c5491defb2022-12-22T01:46:37ZengBMCWorld Journal of Surgical Oncology1477-78192013-01-011111310.1186/1477-7819-11-13Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumorRomeo MargaritaPons FrancescBarretina PilarRadua Joaquim<p>Abstract</p> <p>Background</p> <p>Borderline ovarian tumors (BOTs) are a subset of epithelial ovarian tumors with low malignant potential but significant risk of relapse (10% to 30%). Unfortunately, surgical prognostic factors for BOT relapse have not been clearly identified, probably due to the use of heterogeneous surgical definitions and limited follow-up. The aim of this study was to assess potential relapse risk factors using standard surgical definitions and long follow-up.</p> <p>Methods</p> <p>All patients diagnosed with BOT for a period of more than 10 years in a single institution were included in the analysis. Complete surgical staging was defined as the set of procedures that follow standard guidelines for staging surgery (except lymphadenectomy), performed either with one or two interventions. Fertility-sparing surgeries that preserved one ovary and the uterus but included all the remaining procedures were classified as complete staging. The relationship between potential risk factors and time to BOT relapse was assessed by log-rank tests corrected for multiple comparisons and Cox regression.</p> <p>Results</p> <p>Forty-six patients with a median follow-up of 5.4 years were included, of whom 91.3% had been diagnosed as FIGO stage I disease and 45.7% had received complete staging surgery. Five relapses were detected (10.9%), all of them in women who had been diagnosed with stage I disease and had received incomplete staging surgery. Log-rank tests confirmed the association between incomplete staging surgery and shorter time to BOT relapse.</p> <p>Conclusions</p> <p>Complete staging surgery should be considered a cornerstone of BOT treatment in order to minimize the risk of relapse.</p>http://www.wjso.com/content/11/1/13Borderline ovarian tumorRelapsePrognosisSurgeryStagingRecurrenceFertility-sparing surgery |
| spellingShingle | Romeo Margarita Pons Francesc Barretina Pilar Radua Joaquim Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor World Journal of Surgical Oncology Borderline ovarian tumor Relapse Prognosis Surgery Staging Recurrence Fertility-sparing surgery |
| title | Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor |
| title_full | Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor |
| title_fullStr | Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor |
| title_full_unstemmed | Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor |
| title_short | Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor |
| title_sort | incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor |
| topic | Borderline ovarian tumor Relapse Prognosis Surgery Staging Recurrence Fertility-sparing surgery |
| url | http://www.wjso.com/content/11/1/13 |
| work_keys_str_mv | AT romeomargarita incompletestagingsurgeryasamajorpredictorofrelapseofborderlineovariantumor AT ponsfrancesc incompletestagingsurgeryasamajorpredictorofrelapseofborderlineovariantumor AT barretinapilar incompletestagingsurgeryasamajorpredictorofrelapseofborderlineovariantumor AT raduajoaquim incompletestagingsurgeryasamajorpredictorofrelapseofborderlineovariantumor |